V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240008214 | 240005031 | 1.93 | 89 | null | 2017-05-20 | 2017-06-03 | Triple Intrathecal | N | N | 240004084 | TRIPLE INTRATHECAL |
| 240008215 | 240005032 | 1.7 | 95 | Curative (C) | 2017-02-22 | 2017-02-22 | ICON8 TRIAL | 02 | N | 240004222 | FCR |
| 240008216 | 240005033 | 1.61 | 59.6 | Curative (C) | 2018-01-10 | 2018-01-14 | BEVACIZUMAB + CISPLATIN + PACLITAXEL | 02 | N | 240004240 | MITOXANTRONE |
| 240008217 | 240005033 | 1.74 | null | null | 2016-07-18 | 2016-07-20 | CYTARABINE | N | N | 240004240 | CYTARABINE |
| 240008218 | 240005033 | 1.7 | 72.5 | Adjuvant (A) | null | 2016-03-14 | FLAG + Idarubicin | N | N | 240004240 | BORTEZOMIB |
| 240008219 | 240005034 | null | 67 | Palliative (P) | 2016-11-03 | 2016-11-16 | DHAP | N | N | 240004286 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008220 | 240005035 | 1.45 | 61 | Disease modification (D) | 2017-11-05 | 2017-11-05 | Cisplatin + Etoposide (3 day) | 02 | null | 240004360 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008221 | 240005036 | 1.69 | 99.8 | Palliative (P) | 2014-01-04 | 2014-01-04 | ABVD | 02 | N | 240004446 | AML18 TRIAL |
| 240008222 | 240005036 | 1.52 | 73.5 | Curative (C) | 2016-05-17 | 2016-05-25 | Cyclophosphamide + Dex + Rituximab | N | N | 240004446 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 240008223 | 240005037 | 0 | 62.9 | Palliative (P) | 2018-02-07 | 2018-02-13 | Cisplatin + Etoposide po | 1 | N | 240004510 | CYTARABINE |
| 240008224 | 240005038 | 1.62 | null | Palliative (P) | 2015-09-09 | 2015-09-09 | R-EPOCH | 02 | null | 240004585 | MIDOSTAURIN |
| 240008225 | 240005039 | null | null | null | 2016-08-16 | 2016-08-16 | Capecitabine + Cisplatin | 02 | N | 240004612 | METHOTREXATE INTRATHECAL |
| 240008226 | 240005039 | 1.59 | null | Palliative (P) | null | 2017-12-16 | Bevacizumab 7.5mg/kg | N | null | 240004612 | CISPLATIN + VINORELBINE |
| 240008227 | 240005039 | 1.51 | 74 | Palliative (P) | 2014-10-01 | 2014-10-05 | DOXORUBICIN | 02 | N | 240004612 | CISPLATIN + ETOPOSIDE |
| 240008228 | 240005040 | 1.58 | 55.9 | Curative (C) | 2017-08-03 | 2017-08-07 | CYCLOPHOSPHAMIDE + MESNA | null | N | 240004667 | CVP |
| 240008229 | 240005040 | 1.83 | 80 | Curative (C) | 2017-03-21 | 2017-03-22 | IVE | 02 | N | 240004667 | PILOT TRIAL |
| 240008231 | 240005042 | 1.35 | 54.4 | Palliative (P) | 2016-12-05 | 2016-12-10 | Cisplatin + Paclitaxel | N | N | 240004745 | VENETOCLAX |
| 240008232 | 240010791 | 1.81 | null | Not known (9) | 2018-08-16 | 2018-08-21 | LENALIDOMIDE | 02 | N | 240004768 | CISPLATIN + PEMETREXED |
| 240008234 | 240005044 | null | 65.6 | Palliative (P) | 2014-04-06 | 2014-04-09 | Cisplatin + Doxorubicin | 1 | N | 240004826 | CHLVPP |
| 240008235 | 240010792 | null | null | Curative (C) | null | 2015-06-30 | CHOP-R + CYTARABINE HIGH DOSE | N | N | 240004839 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 240008236 | 240005045 | 1.83 | 84.6 | Curative (C) | 2013-12-10 | 2013-12-16 | DA-EPOCH-R | N | N | 240004919 | TRIPLE INTRATHECAL |
| 240008237 | 240005046 | 1.61 | 76.7 | Palliative (P) | 2013-09-08 | 2013-09-09 | Cisplatin + Doxorubicin | N | N | 240004950 | BCG |
| 240008238 | 240005047 | 1.66 | 72.8 | Adjuvant (A) | 2013-09-30 | 2013-10-01 | Gemcitabine 1000mg/m2 D1 8 15 | null | N | 240005033 | BEVACIZUMAB + CISPLATIN + PACLITAXEL |
| 240008239 | 240005048 | null | 77 | Palliative (P) | 2014-06-08 | 2014-06-11 | DOXORUBICIN | N | N | 240005066 | BEVACIZUMAB |
| 240008240 | 240010793 | 1.51 | 0 | Palliative (P) | 2017-09-02 | 2017-09-03 | Cetuximab 7 day (Cycle 1) | 02 | N | 240005080 | LACE |
| 240008241 | 240005049 | null | null | Palliative (P) | 2014-05-14 | 2014-05-14 | GemCarbo Days 1+8 | 02 | N | 240005082 | VINBLASTINE |
| 240008242 | 240005050 | 1.6 | 65.8 | Disease modification (D) | 2018-04-30 | 2018-05-03 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | N | N | 240005096 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008244 | 240005052 | 1.3 | 69 | Curative (C) | 2017-07-10 | 2017-07-18 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 240005145 | ATG + BUSULFAN + FLUDARABINE |
| 240008245 | 240005053 | 1.71 | 69 | Palliative (P) | 2016-12-12 | 2016-12-12 | Enzalutamide | 02 | N | 240005299 | CYTARABINE |
| 240008246 | 240010794 | 1.72 | 72 | Palliative (P) | 2018-01-09 | 2018-01-09 | VEPEMB | 2 | N | 240005321 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240008247 | 240005054 | 1.65 | null | Curative (C) | 2017-12-17 | 2017-12-20 | R-EPOCH | 02 | null | 240005364 | CYCLO + RITUXIMAB + VINCRISTINE |
| 240008248 | 240005055 | 1.7 | 71.7 | Disease modification (D) | 2015-03-24 | 2015-03-31 | Capecitabine + Oxaliplatin 21day | null | N | 240005430 | TRASTUZUMAB EMTANSINE |
| 240008249 | 240010795 | 1.55 | null | Disease modification (D) | 2015-06-13 | 2015-06-15 | CISPLATIN + ETOPOSIDE | N | N | 240005466 | CVP |
| 240008250 | 240005056 | 1.65 | null | Curative (C) | 2015-05-14 | 2015-05-17 | FEC 100 | 2 | N | 240005538 | FCR |
| 240008251 | 240005056 | 1.6 | null | Palliative (P) | 2013-08-21 | 2013-09-12 | CISPLATIN + ETOPOSIDE | 02 | N | 240005538 | CISPLATIN + VINORELBINE |
| 240008252 | 240005057 | 1.65 | 67 | Curative (C) | 2015-10-19 | 2015-10-20 | CARBOPLATIN + IFOSFAMIDE | N | N | 240005562 | CISPLATIN + ETOPOSIDE |
| 240008253 | 240005058 | 1.6 | 43.6 | Curative (C) | 2017-05-13 | 2017-05-13 | CYCLO + RITUXIMAB + VINCRISTINE | 02 | N | 240005572 | NORDIC |
| 240008254 | 240005058 | 1.94 | 60.8 | Palliative (P) | 2015-05-24 | 2015-05-24 | FLAG | 02 | Y | 240005572 | CLADRIBINE |
| 240008255 | 240005059 | 1.7 | 46.7 | Curative (C) | 2017-03-30 | 2017-03-30 | FCR IV - Cycle 1 | N | null | 240005643 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 240008256 | 240005060 | 1.56 | 68.4 | Adjuvant (A) | 2016-08-08 | 2016-08-10 | Bevacizumab 15mg/kg | 02 | N | 240005696 | CISPLATIN + TOPOTECAN |
| 240008257 | 240005060 | 1.6 | 53.8 | Not known (9) | 2014-05-16 | 2014-05-17 | RCEOP | 2 | N | 240005696 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008258 | 240005061 | 1.65 | null | null | null | 2014-12-24 | CISPLATIN + ETOPOSIDE | null | null | 240005838 | TCH |
| 240008259 | 240005062 | null | 61 | null | 2014-03-17 | 2014-03-19 | FLUOROURACIL + OXALIPLATIN | N | N | 240005841 | FLAG + IDARUBICIN |
| 240008260 | 240005062 | 1.71 | 52.2 | Curative (C) | 2018-06-09 | 2018-06-10 | ESHAP R | 02 | N | 240005841 | CISPLATIN + ETOPOSIDE |
| 240008261 | 240005063 | 1.57 | null | Palliative (P) | 2016-09-19 | 2016-09-19 | CYCLO + RITUXIMAB + VINCRISTINE | 02 | N | 240005884 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008262 | 240005064 | 1.63 | 82.6 | Curative (C) | 2018-03-06 | 2018-03-08 | Cisplatin + Topotecan | N | N | 240005912 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240008263 | 240005064 | 1.57 | 62.2 | Curative (C) | 2017-12-07 | 2017-12-08 | ABVD | 1 | N | 240005912 | NORDIC |
| 240008264 | 240005065 | 1.72 | 79 | Disease modification (D) | 2015-07-11 | 2015-07-14 | Cisplatin + Etoposide (3 day) | N | N | 240005929 | CISPLATIN + FLUOROURACIL |
| 240008265 | 240010801 | 1.73 | null | Curative (C) | 2014-12-06 | 2014-12-10 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 240005974 | CAPECITABINE |
| 240008266 | 240005066 | 1.65 | 77 | Palliative (P) | 2018-07-08 | 2018-07-10 | LIPOSOMAL DOXORUBICIN | 2 | N | 240005996 | IMATINIB |